Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 3
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Targeted tDCS Mitigates Dual-Task Costs to Gait and Balance in Older Adults.
Zhou J, Manor B, Yu W, Lo OY, Gouskova N, Salvador R, Katz R, Cornejo Thumm P, Brozgol M, Ruffini G, Pascual-Leone A, Lipsitz LA, Hausdorff JM. Zhou J, et al. Ann Neurol. 2021 Sep;90(3):428-439. doi: 10.1002/ana.26156. Epub 2021 Jul 17. Ann Neurol. 2021. PMID: 34216034 Free PMC article. Clinical Trial.
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain.
Torrent A, Morgades M, García-Calduch O, de Llano MPQ, Montesinos P, Navarro I, Hernández-Rivas JM, Bárez-García A, González-Campos J, Oiartzabal I, Valero M, Cervera M, Zudaire T, Albors-Ferreiro M, López-Godino O, Gil-Cortés C, Villalón L, Saldaña R, Ribera JM. Torrent A, et al. Eur J Haematol. 2023 Sep;111(3):485-490. doi: 10.1111/ejh.14031. Epub 2023 Jun 28. Eur J Haematol. 2023. PMID: 37381686
A MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers.
Khamina K, Diendorfer AB, Skalicky S, Weigl M, Pultar M, Krammer TL, Fournier CA, Schofield AL, Otto C, Smith AT, Buchtele N, Schoergenhofer C, Jilma B, Frank BJH, Hofstaetter JG, Grillari R, Grillari J, Ruprecht K, Goldring CE, Rehrauer H, Glaab WE, Hackl M. Khamina K, et al. Int J Mol Sci. 2022 Jan 22;23(3):1226. doi: 10.3390/ijms23031226. Int J Mol Sci. 2022. PMID: 35163149 Free PMC article.
Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
Pagano E, Konings SRA, Di Cuonzo D, Rosato R, Bruno G, van der Heijden AA, Beulens J, Slieker R, Leal J, Feenstra TL. Pagano E, et al. Diabetes Obes Metab. 2021 May;23(5):1084-1091. doi: 10.1111/dom.14311. Epub 2021 Jan 22. Diabetes Obes Metab. 2021. PMID: 33377255 Free article.
AIM: To externally validate the UK Prospective Diabetes Study Outcomes Model version 2 (UKPDS-OM2) by comparing the predicted and observed outcomes in two European population-based cohorts of people with type 2 diabetes. MATERIALS AND METHODS: We used data from the …
AIM: To externally validate the UK Prospective Diabetes Study Outcomes Model version 2 (UKPDS-OM2) by comparing the predicted and observed o …
Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting.
Angelini L, Hodgkinson W, Smith C, Dodd JM, Sharrack B, Mazzà C, Paling D. Angelini L, et al. J Neurol. 2020 Oct;267(10):2897-2909. doi: 10.1007/s00415-020-09928-8. Epub 2020 May 28. J Neurol. 2020. PMID: 32468119 Free PMC article.
Gait disability in people with progressive multiple sclerosis (MS) is difficult to quantify using existing clinical tools. ...These abnormalities significantly increased in people with a higher level of disability and correlated with their EDSS scores. ...
Gait disability in people with progressive multiple sclerosis (MS) is difficult to quantify using existing clinical tools. ...These a …
13 results